rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

PolyPid Ltd. -

PYPD · Nasdaq

Health CareMedical DevicesJust dropped out

PYPD stood above a rising 150-day average in 49 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 0.9% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just dropped out
Weeks in an uptrend
out for 1
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
31 (+12)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 49 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders31+12 on the quarter
New · exited12 · 0
Reported value$16.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
AIGH Capital Management LLCreduced · filed 7 Aug 20261,504,741$7.6M-88,846−5.6%
Rosalind Advisors, Inc.reduced · filed 14 Aug 2026389,455$2.0M-208,471−34.9%
DAFNA Capital Management LLCunchanged · filed 14 Aug 2026207,900$1.1M00.0%
MORGAN STANLEYreduced · filed 13 Aug 2026123,136$626K-53,756−30.4%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026116,619$592K+98,023+527.1%
MARSHALL WACE, LLPnew · filed 13 Aug 2026115,014$584K+115,014
ADAR1 Capital Management, LLCunchanged · filed 14 Aug 2026103,950$528K00.0%
SYMMETRY PEAK MANAGEMENT LLCadded · filed 14 Aug 2026100,881$512K+13,688+15.7%
J. Goldman & Co LPreduced · filed 14 Aug 202699,183$504K-50,316−33.7%
JANE STREET GROUP, LLCadded · filed 14 Aug 202683,126$422K+61,484+284.1%
31 Mar 2023 – 30 Jun 2026
41730Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Brooke Story Company insiderDirector · last 15 Jul 20260 · 0
Dikla Czaczkes Akselbrad Company insiderChief Executive Officer · last 15 Jul 20260 · 0
Itzhak Krinsky Company insiderDirector · last 15 Jul 20260 · 0
Joseph BenAmram Company insiderDirector · last 15 Jul 20260 · 0
Nir Dror-Darwish Company insiderDirector · last 15 Jul 20260 · 0
Robert Benjamin Stein Company insiderDirector · last 15 Jul 20260 · 0
Yechezkel Barenholz Company insiderDirector · last 15 Jul 20260 · 0
Dalit Fellous Hazan Company insiderDeputy CEO, EVP, RD, CRA · last 11 May 20260 · 0
Jonathan Missulawin Company insiderChief Financial Officer · last 11 May 20260 · 0
Ori Warshavsky Company insiderChief Operating Officer - US · last 11 May 20260 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Debt to equityFY 2025 · to 31 Dec 20250.09×
Earnings per share growthFY 2025 · to 31 Dec 2025-57.4%
Share count trendFY 2025 · to 31 Dec 202578.6%
Cash and equivalentsFY 2025 · to 31 Dec 2025$6.4M
Free cash flowFY 2025 · to 31 Dec 2025−$28.1M

Analyst forecasts

No analyst forecasts yet.